TGFB1 and non-small cell lung carcinoma: In the same study, signaling pathways involving proteoglycans, ErbB, fatty acid biosynthesis, Hippo, Rap1, TGF-β, Wnt, AMPK, and Ras were heavily enriched in EVs from NSCLC patients through bioinformatic analysis identification [46].